Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2016 May 1;44(5):548-53.
doi: 10.1016/j.ajic.2015.12.001. Epub 2016 Jan 25.

Prevalence of probiotic use among inpatients: A descriptive study of 145 U.S. hospitals

Affiliations
Observational Study

Prevalence of probiotic use among inpatients: A descriptive study of 145 U.S. hospitals

Sarah H Yi et al. Am J Infect Control. .

Abstract

Background: To inform clinical guidance, public health efforts, and research directions, probiotic use in U.S. health care needs to be better understood. This work aimed to assess the prevalence of inpatient probiotic use in a sample of U.S. hospitals.

Methods: Probiotic use among patients discharged in 2012 was estimated using the MarketScan Hospital Drug Database. In addition, the annual trend in probiotic use (2006-2012) was assessed among a subset of hospitals.

Results: Among 145 hospitals with 1,976,167 discharges in 2012, probiotics were used in 51,723 (2.6%) of hospitalizations occurring in 139 (96%) hospitals. Patients receiving probiotics were 9 times more likely to receive antimicrobials (P < .0001) and 21 times more likely to have a Clostridium difficile infection diagnosis (P < .0001). The most common probiotic formulations were Saccharomyces boulardii (32% of patients receiving probiotics), Lactobacillus acidophilus and Lactobacillus bulgaricus (30%), L acidophilus (28%), and Lactobacillus rhamnosus (11%). Probiotic use increased from 1.0% of 1,090,373 discharges in 2006 to 2.9% of 1,006,051 discharges in 2012 (P < .0001).

Conclusions: In this sample of U.S. hospitals, a sizable and growing number of inpatients received probiotics as part of their care despite inadequate evidence to support their use in this population. Additional research is needed to guide probiotic use in the hospital setting.

Keywords: Bifidobacterium; Dietary supplement; Lactobacillus; Probiotic; Saccharomyces; hospital; microbial; prevalence.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None to report.

Figures

Fig 1.
Fig 1.
Trend in probiotic use among 60 U.S. hospitals reporting annually, HDD, 2006-2012. Corresponding data table is displayed in Supplemental Table S7. HDD, MarketScan Hospital Drug Database; 4 species formulation consists of Lactobacillus acidophilus, Streptococcus thermophilus,Lactobacillus paracasei, and Bifidobacterium animalis.

References

    1. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014;11:506–14. - PubMed
    1. Rodgers B, Kirley K, Mounsey A. PURLs: prescribing an antibiotic? Pair it with probiotics. J Fam Pract 2013;62:148–50. - PMC - PubMed
    1. Brown K, Valenta K, Fisman D, Simor A, Daneman N. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection. JAMA Intern Med 2015;175:626–33. - PubMed
    1. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012;307:1959–69. - PubMed
    1. Pattani R, Palda VA, Hwang SW, Shah PS. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis. Open Med 2013;7:e56–67. - PMC - PubMed

Publication types